Table 4.
Adverse event, n (%) | All subjects (N=22) |
---|---|
Total | 12 (54.5) |
Headache | 6 (27.3) |
Dry skin | 2 (9.1) |
Myalgia | 2 (9.1) |
Nasopharyngitis | 2 (9.1) |
Nausea | 2 (9.1) |
Diarrhea | 1 (4.5) |
Dizziness | 1 (4.5) |
Erythema | 1 (4.5) |
Oral herpes | 1 (4.5) |
Phlebitis | 1 (4.5) |
Rhinitis | 1 (4.5) |
Vaginal hemorrhage | 1 (4.5) |
Vomiting | 1 (4.5) |
Note: All adverse events were grade 1 or 2.